SBI Pharma Fund - Direct (G)

Fund Class : Equity - Pharma
Fund House : SBI Mutual Fund
Aum(Rs Cr) : 65.14
NAV 20 Sep 2017 132.09 1.29
(0.99%)

NAV High-Low (in Rs)

ONE Mth 981.28
981.28
52-WEEk 847.18
1082.59

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes 2.88 5.59 - - 6.19
Sensex 0.4 3.55 9.78 13.55 19.49
Nifty 0.35 3.77 10.97 15.32 24.63

Fund Features

Types of Scheme Growth
Options Equity
Assets Size (Rs in Cr) 65.14 (31 Jan 13)
Inception Date 01 Jan 13
Fund Manager Tanmaya Desai

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid (Rs)
Entry Load 0.00%
EXIT Load 0.00.

Fund Activity

   As On 31 Aug 2017
Category Share (%)
Cash & Bank Balance & Bank Deposits 0.05
CBLO 9.30
Equity 93.25
› More
   As On 31 Aug 2017
Sector Name Amount
Healthcare 13.25
NA 9.35
Pharmaceuticals - Indian - Bulk Drugs 16.40
Pharmaceuticals - Indian - Bulk Drugs & Formln 52.49
Pharmaceuticals - Indian - Formulations 8.02
Pharmaceuticals - Multinational 3.09
› More
   As On 31 Aug 2017
Company Name
Cipla 10.02
Aurobindo Pharma 9.98
Divi's Lab. 8.52
Strides Shasun 8.30
Cadila Health. 5.10
Natco Pharma 4.69
Alkem Lab 4.56
Torrent Pharma. 4.42
› More

Fund DETAILS

Asset Management Co.

Registered Address

SBI Funds Management Ltd,

9th floorCrescenzoC-39&39
G BlockBandra-kurla complex
Bandra (east)Mumbai-400 051.

Phone: 022-61793000 | Fax: 022-2218 9663

Email: partnerforlife@sbimf.com

Website: www.sbimf.com